Our editorial approach
We gather information from registries, scientific literature, official public-health guidance and reputable secondary sources. When we summarize a finding we link readers to the underlying registry or study where possible so they can inspect methods and limitations themselves.
To support those claims, we cite authoritative resources: for example, standards and registry practice are commonly described on government health sites like the U.S. National Library of Medicine (nlm.nih.gov) and foundational concepts about evidence and study types are explained in reference works such as the Clinical trial entry on Wikipedia.
What we cover
Content is organized into thematic sections: summaries of evidence, safety considerations, legal context, and practical questions for researchers. Editorial pages link out to primary sources and neighboring pages within the site—our Services page describes services we document and how to interpret provider claims in public materials.
How we vet information
We prioritize primary registries, peer-reviewed studies, and official guidance. When citing research, we examine sample size, design, conflict-of-interest statements, and regulatory context before presenting an aggregated view to readers.
When we refer to regulatory frameworks or public policy we often cross-check with university and government resources such as those hosted by major research universities (harvard.edu) to confirm interpretations of policy language.
Editorial principles
- Independence — no treatment offers or clinic affiliations.
- Plain language — accessible summaries for non-specialists.
- Evidence transparency — link to primary sources where possible.
- Audience focus — content tailored to people researching ibogaine.
Who this is for
This resource is intended for people researching ibogaine who need clear, dispassionate summaries and pointers to primary evidence. If you are seeking clinical care, please consult licensed providers and local authorities rather than relying on this site as medical guidance.
Independent by design
What Is Ibogaine is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice.